Announcements Trials
Browse Landscape

Status

Completed 1559Recruiting 836Unknown 506Terminated 395Active not recruiting 217Not yet recruiting 198Withdrawn 91Suspended 25Enrolling by invitation 21No longer available 9Available 2Approved for marketing 1

Sponsor Class

INDUSTRY 1

Study Type

Expanded_access 1

Sponsor

Cancer Type

Thoracic 17Gastrointestinal 13Other hematologic neoplasm 12Genitourinary 12Lymphoid 10Breast 10CNS 7Plasma cell 6Head & Neck 5Endocrine 5Sarcoma 4Tumor-Agnostic 3Dermatologic 3NET 2Myeloid 2Gynecologic 2Other solid neoplasm 1

Conditions

Mesothelioma 1

Interventions

Pemetrexed 1Cisplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Approved for marketing × Other solid neoplasm × Clear all
NCT00040625 2007-03-15

ALIMTA (Pemetrexed) Alone or in Combination With Cisplatin for Patients With Malignant Mesothelioma.

Eli Lilly and Company

Approved for marketing
Other solid neoplasmThoracic

Mesothelioma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡